parathyroid hormone

Type: Keyphrase

Name: parathyroid hormone

First reported 17 hours ago - Updated 7 mins ago - 2 reports

Calcium and vitamin D intake timing may affect how bone adapts to exercise

Washington, June 19 (ANI): Taking calcium and vitamin D before exercise may influence how bones adapt to exercise, according to a new study.The study lead author Vanessa D. Sherk, PhD, postdoctoral research fellow at the University of Colorado Anschutz ... [Published News Track India - 43 mins ago]

Entities: Calcium, Vitamin D, Anschutz Medical Campus, parathyroid hormone, Supplement

First reported Jun 17 2013 - Updated Jun 17 2013 - 1 reports

Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients with Hypoparathyroidism

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, yesterday presented findings supporting the ... [Published Enhanced Online News - Jun 17 2013]

Entities: parathyroid hormone, Hypoparathyroidism, Hormone Replacement Therapy

First reported Jun 14 2013 - Updated Jun 15 2013 - 1 reports

Ernst & Young

NPS Pharmaceuticals’ CEO Dr. Francois Nader Receives Ernst & Young Entrepreneur Of The Year 2013 Award in New Jersey

-- Award recognizes entrepreneurial excellence in life sciences --BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare ... [Published Citybizlist - Jun 14 2013]

Entities: Ernst & Young, NPS Pharmaceuticals Inc, Francois Nader, Entrepreneur

First reported Jun 12 2013 - Updated Jun 12 2013 - 1 reports

Rockwell Medical Technologies Inc

Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical

On May 29th, Rockwell Medical (RMTI) announced it had completed patient dosing in its efficacy and safety study of SFP-iron (Soluble Ferric Pyrophosphate-iron). The drug is delivered via dialysate (dialysis fluid) for adult patients with chronic kidney ... [Published Seeking Alpha - Jun 12 2013]

Entities: Rockwell Medical Technologies Inc, calcitriol, Phase III, Hemoglobin

First reported Jun 12 2013 - Updated Jun 12 2013 - 1 reports

Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events ...

The Canadian Study of Prediction of Death, Dialysis and Interim Cardiovascular Events (CanPREDDICT) is a large, prospective, pan-Canadian, cohort study designed to improve our understanding of determinants of renal and cardiovascular (CV) disease progression ... [Published 7thSpace - Jun 12 2013]

Entities: Cohort, Dialysis, parathyroid hormone, Patient, Kidney

First reported Jun 02 2013 - Updated Jun 02 2013 - 1 reports

Healthbeat: Reducing your risk of kidney stones

Kidney stones can be extremely painful when they decide to exit the body. They are also very common — about 10 percent of Americans form them at one time or another.For some people, they occur more than once. They can happen at any age, but are more common ... [Published Portsmouth Herald - Jun 02 2013]

Entities: Calcium, Uric Acid, Calcitonin, Protein, parathyroid hormone

First reported May 31 2013 - Updated May 31 2013 - 2 reports

NPS Pharmaceuticals Joins the Hypoparathyroidism Association in Recognition of World Hypoparathyroid

Filed under: Investing ism Awareness DayCompany Launches Interactive Awareness Campaign at Hypoparathyroidism.comBEDMINSTER, N.J.--( BUSINESS WIRE )-- NPS Pharmaceuticals, Inc. ( NAS: NPSP ) , a biopharmaceutical company pioneering and delivering therapies ... [Published Daily Finance - May 31 2013]

Entities: Hypoparathyroidism, NPS Pharmaceuticals Inc, GATTEX, Calcium

First reported May 31 2013 - Updated May 31 2013 - 1 reports

Researchers at Columbia University Report Findings in Bone Research

(NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Bone Research. According to news originating from New York City, New York, by NewsRx correspondents, research stated, "Hypoparathyroidism ... [Published NewsRX - May 31 2013]

Entities: parathyroid hormone, Hypoparathyroidism, Columbia University

First reported May 31 2013 - Updated May 31 2013 - 1 reports

Reports Outline Cardiology Findings from National Taiwan University

(NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Data detailed on Cardiology have been presented. According to news reporting originating in Taipei, Taiwan, by NewsRx journalists, research stated, "Vitamin D receptor modulators ... [Published NewsRX - May 31 2013]

Entities: National Taiwan University, Cardiology, parathyroid hormone, Serum

First reported May 29 2013 - Updated May 29 2013 - 1 reports

NPS Pharmaceuticals' Management Presents at 38th Annual dbAccess Health Care Conference (Transcript)

NPS Pharmaceuticals, Inc. (NPSP) 38th Annual dbAccess Health Care Conference Call May 29, 2013 8:00 AM ETOlivia Young – Deutsche Bank Securities, Inc.Hey guys, it’s Olivia Young here, I am an analyst from the Biotech team at Deutsche Bank, welcome and ... [Published Seeking Alpha - May 29 2013]

Entities: GATTEX, Hypoparathyroidism, parathyroid hormone, Patient

First reported May 29 2013 - Updated May 29 2013 - 1 reports

Opko Launches Phase 3 Trial of Rayaldy

Opko Health has surpassed 50 percent enrollment in phase 3 trial of Rayaldy to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency. According to a release, this trial is one of ... [Published Individual.com - May 29 2013]

Entities: Vitamin D, parathyroid hormone, Phase III, Patient, Secondary hyperparathyroidism

First reported May 29 2013 - Updated May 29 2013 - 1 reports

Boning Up on Nutrition: Food Manufacturers Take a Closer Look at Dietary Calcium

The bones that provide the human body with form and structure and allow us to move with speed and grace are part of a complex and metabolically active system. The bones are a matrix of protein filled in with minerals, principally calcium, the most abundant ... [Published FoodProcessing.com - May 29 2013]

Entities: Calcium, Mineral, Vitamin D

Quotes

"Taking calcium before exercise may help keep blood levels more stable during exercise, compared to taking the supplement afterwards, but we do not yet know the long-term effects of this on bone density" Sherk said

Calcium and vitamin D intake timing may affect how bone adapts to exercise [Published News Track India - 43 mins ago]

"DRL has committed and will commit acts of infringement of the patents-in-suit that create a justiciable case or controversy between plaintiffs and DRL" the petitioners alleged

Dr Reddy's sued for 'infringement' of thyroid injection patent [Published zeenews.com - 3 hours ago]

"I'm truly honored to accept this award and be recognized by Ernst & Young among the successful entrepreneurs in New Jersey," said Dr. Nader. "It's an exciting moment for the entire NPS team, which has achieved so much and works so hard each and every day to bring innovative therapeutics to patients suffering from rare diseases around the world."

NPS Pharmaceuticals' President and CEO Wins Ernst & Young Entrepreneur Of The Year 2013 Award [Published Individual.com - 4 hours ago]

"These findings are relevant to individuals who engage in vigorous exercise and may lose a substantial amount of calcium through sweating" Sherk said...

Timing of calcium and vitamin D supplementation may affect how bone adapts to exercise [Published EurekAlert! - 17 hours ago]

More Content

sort by: Date \| Relevance
Calcium and vitamin D intake timing may affect ... [Published News Track India - 43 mins ago]
Dr Reddy's Lab slips on buzz of patent infringe... [Published India Infoline - 1 hour ago]
Dr Reddy's sued for 'infringement' of thyroid i... [Published zeenews.com - 3 hours ago]
NPS Pharmaceuticals' President and CEO Wins Ern... [Published Individual.com - 4 hours ago]
Timing of calcium and vitamin D supplementation... [Published EurekAlert! - 17 hours ago]
Rockwell Medical Receives $20 Mln from Hercules... [Published PE Hub News - 19 hours ago]
Rockwell Medical Receives $20 Million in New Fi... [Published Individual.com - 21 hours ago]
MannKind Completes Phase 3 Clinical Study of AF... [Published BioMedReports - Jun 18 2013]
Eli Lilly's CEO Presents at Goldman Sachs Healt... [Published Seeking Alpha - Jun 17 2013]
Findings Presented at ENDO 2013 Support Therape... [Published Enhanced Online News - Jun 17 2013]
Findings Presented at ENDO 2013 Support Therape... [Published Business Wire Health News - Jun 17 2013]
Osteoporosis: Treatment with 2 osteoporosis dru... [Published NewsRX - Jun 17 2013]
NPS Pharmaceuticals’ CEO Dr. Francois Nader Rec... [Published Citybizlist - Jun 14 2013]
Eli Lilly & Co CEO Presents at Goldman Sachs He... [Published Seeking Alpha - Jun 12 2013]
Multiple Pending Catalysts Should Keep Investor... [Published Seeking Alpha - Jun 12 2013]
Cohort profile: Canadian study of prediction of... [Published 7thSpace - Jun 12 2013]
Teriparatide 'more effective than risedronate' ... [Published Arthritis Research UK - Jun 11 2013]
Prevalence of Ventricular Arrhythmia and Its As... [Published Elites TV - Jun 10 2013]
Solid formulations of the recombinant anthrax v... [Published News-Medical.Net - Jun 06 2013]
NPS Pharmaceuticals Partners with the Hypoparat... [Published Individual.com - Jun 05 2013]
The Profitable Business of Developing Orphan Drugs [Published Motley Fool - Jun 04 2013]
NPS Pharmaceuticals: Don't Fret About The $295,... [Published Seeking Alpha - Jun 03 2013]
Healthbeat: Reducing your risk of kidney stones [Published Portsmouth Herald - Jun 02 2013]
NPS Pharmaceuticals Joins the Hypoparathyroidis... [Published Pharmaceutical & Medical Packaging News - May 31 2013]
Researchers at Columbia University Report Findi... [Published NewsRX - May 31 2013]
NPS Pharmaceuticals Joins the Hypoparathyroidis... [Published Daily Finance - May 31 2013]
NPS Pharmaceuticals Joins the Hypoparathyroidis... [Published Reuters - May 31 2013]
Reports Outline Cardiology Findings from Nation... [Published NewsRX - May 31 2013]
Treatment with 2 osteoporosis drugs better at i... [Published Pharmacy Choice - May 30 2013]
NPS Pharmaceuticals' Management Presents at 38t... [Published Seeking Alpha - May 29 2013]

sort by: Date \| Relevance
Is It Primal? – Soda Water, Listerine, Ta... [Published Mark's Daily Apple - Apr 23 2013] <p><img class="alignright" alt="sodawater" src="http://i247.photobucket.com/albums/gg158/MDA2008/MDA%202011/sodawater.jpg" width="320" height="211" title="Is It Primal?Soda Water, Listerine, Tamarind, and Other Foods Scrutinized"/>It’s time for another ...
NPS Pharma regains teduglutide, PTH 1-84 worldw... [Published PBR - News - Mar 20 2013] NPS Pharmaceuticals has regained complete worldwide rights to develop and commercialize teduglutide and recombinant human parathyroid hormone 1-84 (PTH 1-84) from Takeda Pharmaceutical. ...